Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03581474 · ClinicalTrials.gov registry record · NA
Evaluation of BAL Procedure With Ambu aScope 3 Large in Patients in an ICU Setting
A NA study, sponsored by Ambu A/S.
- Terminated
- Registry status
- NA
- Development phase
- 12
- Enrollment target
NCT03581474 is a NA study that was terminated before completion, run by Ambu A/S. The registered enrollment target is 12 participants.
The verdict
NCT03581474, a NA study, was terminated before completion, sponsored by Ambu A/S.
- TERMINATED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
Study Summary
An Investigation to determine the single-use scope's ability to suction secretion from the lungs to resolve the collapse of the lung.
Interventions
- DEVICE Bronchoscopic procedure
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2017-09-28 |
| Est. Completion | 2018-07-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03581474
The ClinicalTrials.gov registry entry for NCT03581474 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ambu A/S, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Bronchoscopic procedure is the first listed.
NCT03581474 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03581474 about?
NCT03581474 is a clinical study titled "Evaluation of BAL Procedure With Ambu aScope 3 Large in Patients in an ICU Setting". An Investigation to determine the single-use scope's ability to suction secretion from the lungs to resolve the collapse of the lung.
What is the current status of trial NCT03581474?
This trial is currently terminated. It is a NA study. The enrollment target is 12 participants. The study started on 2017-09-28. Estimated completion is 2018-07-03.
What interventions are being tested in trial NCT03581474?
The interventions under investigation include: Bronchoscopic procedure (DEVICE).
Who is sponsoring clinical trial NCT03581474?
This trial is sponsored by Ambu A/S, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.